Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ENOS anticorps (pSer615) (HRP)

L’anticorps Lapin Polyclonal anti-ENOS a été validé pour WB, ELISA, IHC (p) et IHC (fro). Il convient pour détecter ENOS dans des échantillons de Humain.
N° du produit ABIN1712423

Aperçu rapide pour ENOS anticorps (pSer615) (HRP) (ABIN1712423)

Antigène

Voir toutes ENOS (NOS3) Anticorps
ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))

Reactivité

  • 248
  • 134
  • 132
  • 13
  • 11
  • 10
  • 9
  • 6
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Humain

Hôte

  • 257
  • 32
  • 2
Lapin

Clonalité

  • 259
  • 32
Polyclonal

Conjugué

  • 122
  • 25
  • 15
  • 10
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
Cet anticorp ENOS est conjugé à/à la HRP

Application

  • 236
  • 92
  • 84
  • 79
  • 64
  • 49
  • 37
  • 35
  • 31
  • 22
  • 22
  • 8
  • 7
  • 4
  • 3
  • 2
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
  • Épitope

    • 26
    • 24
    • 23
    • 20
    • 17
    • 16
    • 16
    • 10
    • 10
    • 8
    • 8
    • 7
    • 7
    • 6
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pSer615

     Réactivité croisée

    Humain

    Homologie

    Dog,Rabbit

    Purification

    Purified by Protein A.

    Immunogène

    KLH conjugated synthetic phosphopeptide derived from human eNOS around the phosphorylation site of Ser615

    Isotype

    IgG
  • Indications d'application

    WB 1:300-5000
    IHC-P 1:200-400
    IHC-F 1:100-500

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 μg/μL

    Buffer

    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Conseil sur la manipulation

    Do NOT add Sodium Azide! Use of Sodium Azide will inhibit enzyme activity of horseradish peroxidase.

    Stock

    -20 °C

    Stockage commentaire

    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

    Date de péremption

    12 months
  • Antigène

    ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))

    Autre désignation

    eNOS

    Sujet

    Synonyms: eNOS phospho S615, p-eNOS phospho S615, eNOS Ser615, cNOS, eNOS, Constitutive NOS, EC NOS, ecNOS, Endothelial nitric oxidase synthase, Endothelial nitric oxide synthase, Endothelial nitric oxide synthase 3, Endothelial NOS, Nitric oxide synthase 3 endothelial cell, Nitric oxide synthase 3, Nitric oxide synthase 3 endothelial cell, Nitric oxide synthase endothelial, nitric oxide synthase, endothelial, NOS 3, NOS III, NOS type III, NOS3, NOSIII, NOS3_HUMAN.

    Background: eNOS is a calcium/calmodulin dependent enzyme which undergoes several post translational modifications, including acylation with myristate and palmitate, and phosphorylation on numerous residues. As with the other members of the NOS family, eNOS derives the diffusible multifunctional second messenger NO from L arginine through a series of reactions in which L citrulline is an intermediate. eNOS plays an important role in controlling vascular tone, platelet aggregation, and cardiac myocyte function.

    ID gène

    4846

    Pathways

    ACE Inhibitor Pathway, Regulation of Systemic Arterial Blood Pressure by Hormones, Cellular Response to Molecule of Bacterial Origin, Myometrial Relaxation and Contraction, Signaling Events mediated by VEGFR1 and VEGFR2, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Vous êtes ici:
Chat with us!